RECURRENT GLIOMA
Clinical trials for RECURRENT GLIOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT GLIOMA trials appear
Sign up with your email to follow new studies for RECURRENT GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise for tough brain cancers
Disease control Recruiting nowThis phase 2 trial tests the drug erdafitinib in 30 adults with a specific type of brain tumor (IDH-wild type glioma) that has come back or is getting worse. The tumor must have a certain gene fusion (FGFR-TACC). Erdafitinib blocks a faulty protein that helps cancer cells grow. T…
Matched conditions: RECURRENT GLIOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a common diabetes drug help fight brain tumors?
Disease control Recruiting nowThis early-phase trial is testing whether sitagliptin, a drug used for diabetes, can help treat recurrent grade 4 glioma (a severe brain cancer) when combined with the standard drug bevacizumab. The study involves 45 adults whose cancer has returned after initial treatment. Resea…
Matched conditions: RECURRENT GLIOMA
Phase: PHASE1 • Sponsor: Kailin Yang, MD, PhD • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New proton beam approach may offer hope for aggressive brain tumors
Disease control Recruiting nowThis study is testing a special type of proton radiation called PRDR for people whose fast-growing brain tumor (high-grade glioma) has come back after prior treatment. The goal is to see if this radiation can help control the tumor and improve survival while keeping side effects …
Matched conditions: RECURRENT GLIOMA
Phase: NA • Sponsor: Baptist Health South Florida • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Engineered immune cells take on glioblastoma in early trial
Disease control Recruiting nowThis early-stage trial is testing a new treatment called CARv3-TEAM-E T cells for people with glioblastoma, a serious brain cancer that has come back. The treatment uses a patient's own immune cells that are modified in a lab to better recognize and attack the cancer. The main go…
Matched conditions: RECURRENT GLIOMA
Phase: PHASE1 • Sponsor: Marcela V. Maus, M.D.,Ph.D. • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New Four-in-One antibody takes on Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase study tests a new drug called GNC-039 in people with advanced solid tumors, including a type of brain cancer called glioma, that have come back or spread. The main goals are to check the drug's safety, find the best dose, and see if it can help control the diseas…
Matched conditions: RECURRENT GLIOMA
Phase: PHASE1 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
App-Based home care for brain tumors under study
Knowledge-focused Recruiting nowThis study tests whether a mobile app can help people with glioma (a type of brain tumor) receive care at home instead of traveling to a specialist center. About 120 adults with glioma who need ongoing treatment will use the app to stay in touch with their care team. The main goa…
Matched conditions: RECURRENT GLIOMA
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC